NATURE’S SUNSHINE PRODUCTS, INC. Increase Decrease In Operating Lease Liability
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Increase Decrease In Operating Lease Liability of -$1.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$1.01M.
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$245.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.18M.
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$1.20M.
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for fiscal 2025 was -$5.06M.
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for fiscal 2024 was -$5.57M.
- NATURE’S SUNSHINE PRODUCTS, INC. increase decrease in operating lease liability for fiscal 2023 was -$4.71M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.25M 10-Q · filed 2026-08-06 | -$2.43M derived: sum of 3 quarters · filed 2026-08-06 | -$3.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$245.00K 10-Q · filed 2026-05-07 | -$1.42M derived: sum of 2 quarters · filed 2026-05-07 | -$2.62M derived: sum of 3 quarters · filed 2026-05-07 | -$3.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$2.38M derived: sum of 2 quarters · filed 2026-03-10 | -$3.56M derived: sum of 3 quarters · filed 2026-08-06 | -$5.06M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.38M derived: sum of 2 quarters · filed 2026-08-06 | -$3.88M 10-Q · filed 2025-11-06 | -$4.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.68M 10-Q · filed 2026-08-06 | -$3.76M derived: sum of 3 quarters · filed 2026-08-06 | -$5.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.50M 10-Q · filed 2026-05-07 | -$2.58M derived: sum of 2 quarters · filed 2026-05-07 | -$3.85M derived: sum of 3 quarters · filed 2026-05-07 | -$6.07M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$2.35M derived: sum of 2 quarters · filed 2026-03-10 | -$4.57M derived: sum of 3 quarters · filed 2026-03-10 | -$5.57M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.49M derived: sum of 2 quarters · filed 2025-11-06 | -$4.49M 10-Q · filed 2025-11-06 | -$5.79M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$3.21M 10-Q · filed 2025-07-31 | -$4.51M derived: sum of 3 quarters · filed 2025-07-31 | -$5.88M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$1.00M 10-Q · filed 2025-05-06 | -$2.29M derived: sum of 2 quarters · filed 2025-05-06 | -$3.67M derived: sum of 3 quarters · filed 2025-05-06 | |
| 2023-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$2.67M derived: sum of 2 quarters · filed 2025-03-11 | -$4.71M 10-K · filed 2025-03-11 | |
| 2023-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.41M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | -$2.04M 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |